Full Product Name
GLIS2 antibody - N-terminal region
Product Gene Name
anti-GLIS2 antibody
[Similar Products]
Product Synonym Gene Name
NKL; NPHP7[Similar Products]
Antibody/Peptide Pairs
GLIS2 peptide (MBS3224826) is used for blocking the activity of GLIS2 antibody (MBS3200138)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence
Synthetic peptide located within the following region: LSPPSGLDSP NGSSSLSPER QGNGDLPPVP SASDFQPLRY LDGVPSSFQF
3D Structure
ModBase 3D Structure for Q9BZE0
Species Reactivity
Dog, Guinea Pig, Horse, Human, Mouse, Rabbit, Rat
Purity/Purification
Protein A purified
Form/Format
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Homology
Dog: 92%; Guinea Pig: 86%; Horse: 77%; Human: 100%; Mouse: 83%; Rabbit: 85%; Rat: 92%
Immunogen
The immunogen is a synthetic peptide directed towards the N terminal region of human GLIS2
Preparation and Storage
For short term use, store at 2-8 degree C up to 1 week. For long term storage, store at -20 degree C in small aliquots to prevent freeze-thaw cycles.
Other Notes
Small volumes of anti-GLIS2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-GLIS2 antibody
This is a rabbit polyclonal antibody against GLIS2. It was validated on Western Blot using a cell lysate as a positive control.
Target Description: Members of the Kruppel-like zinc finger protein family, such as GLIS2, function as activators and/or repressors of gene transcription.[supplied by OMIM].
Product Categories/Family for anti-GLIS2 antibody
Polyclonal; Transcription Factor; Transcription Regulation; Cell Biology; Neuroscience; Stem Cells; Transcription Factors; Cell Differentiation;
Applications Tested/Suitable for anti-GLIS2 antibody
Western Blot (WB)
Western Blot (WB) of anti-GLIS2 antibody
WB Suggested Anti-GLIS2 Antibody Titration: 2.5ug/ml
ELISA Titer: 1:12500
Positive Control: HepG2 cell lysate

NCBI/Uniprot data below describe general gene information for GLIS2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_115964
[Other Products]
NCBI GenBank Nucleotide #
NM_032575
[Other Products]
UniProt Primary Accession #
Q9BZE0
[Other Products]
UniProt Related Accession #
Q9BZE0[Other Products]
NCBI Official Full Name
zinc finger protein GLIS2
NCBI Official Synonym Full Names
GLIS family zinc finger 2
NCBI Official Symbol
GLIS2??[Similar Products]
NCBI Official Synonym Symbols
NKL; NPHP7
??[Similar Products]
NCBI Protein Information
zinc finger protein GLIS2
UniProt Protein Name
Zinc finger protein GLIS2
UniProt Synonym Protein Names
GLI-similar 2; Neuronal Krueppel-like protein
Protein Family
Zinc finger protein
UniProt Gene Name
GLIS2??[Similar Products]
UniProt Synonym Gene Names
NKL??[Similar Products]
UniProt Entry Name
GLIS2_HUMAN
NCBI Summary for GLIS2
This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear transcription factor with five C2H2-type zinc finger domains. The protein encoded by this gene is widely expressed at low levels in the neural tube and peripheral nervous system and likely promotes neuronal differentiation. It is abundantly expressed in the kidney and may have a role in the regulation of kidney morphogenesis. p120 regulates the expression level of this protein and induces the cleavage of this protein's C-terminal zinc finger domain. This protein also promotes the nuclear translocation of p120. Mutations in this gene cause nephronophthisis (NPHP), an autosomal recessive kidney disease characterized by tubular basement membrane disruption, interstitial lymphohistiocytic cell infiltration, and development of cysts at the corticomedullary border of the kidneys.[provided by RefSeq, Jan 2010]
UniProt Comments for GLIS2
GLIS2: Can act either as a transcriptional repressor or as a transcriptional activator, depending on the cell context. Acts as a repressor of the Hedgehog signaling pathway. Represses the Hedgehog-dependent expression of Wnt4. Necessary to maintain the differentiated epithelial phenotype in renal cells through the inhibition of SNAI1, which itself induces the epithelial-to-mesenchymal transition. Represses transcriptional activation mediated by CTNNB1 in the Wnt signaling pathway. May act by recruiting the corepressors CTBP1 and HDAC3. May be involved in neuron differentiation. Defects in GLIS2 are the cause of nephronophthisis type 7 (NPHP7). NPHP7 is an autosomal recessive disorder resulting in end-stage renal disease during childhood or adolescence. It is a progressive tubulo-interstitial kidney disorder histologically characterized by modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts. Belongs to the GLI C2H2-type zinc-finger protein family.
Protein type: C2H2-type zinc finger protein
Chromosomal Location of Human Ortholog: 16p13.3
Cellular Component: cytoplasm; nuclear speck; nucleus
Molecular Function: protein binding; metal ion binding
Biological Process: nervous system development; transcription, DNA-dependent; negative regulation of transcription factor activity; negative regulation of smoothened signaling pathway; positive regulation of transcription, DNA-dependent; positive regulation of transcription from RNA polymerase II promoter; negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; cell differentiation
Disease: Nephronophthisis 7
Research Articles on GLIS2
1. Study confirmed that high expression of GLIS2 is significantly associated with chemoresistance and a worse prognosis in gastric cancer, and that this high expression is likely to be an important biomarker.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.